Chinese herbs of shenghe powder reverse multidrug resistance of gastric carcinoma SGC-7901

Integrative Cancer Therapies

Volumn 6, Issue 4, 2007, Pages 400-404

  Jianhua Wang, ^a   Yuesheng Xia, ^a   Huan Wang, ^b   Zengxia Hou, ^c  

^a Fifth Staff Hospital   (China)

^b Shanxi College of Traditional Chinese Medicine   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bcl 2; Chinese herbs; Multidrug resistance; P glycoprotein

Indexed keywords

CHINESE DRUG; GLYCOPROTEIN P; PROTEIN BCL 2; SGC 7901; SHENGHE; UNCLASSIFIED DRUG; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL CULTURE; CHINESE HERB; CONTROLLED STUDY; DRUG FORMULATION; DRUG INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA; LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUGS, CHINESE HERBAL; HUMANS; INTRACELLULAR SPACE; P-GLYCOPROTEIN; POWDERS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; VERAPAMIL; VINCRISTINE;

EID: 36248970069     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735407309765     Document Type: Article

References (17)

1. Lage H. MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. Curr Drug Targets. 2006 ; 7: 813-821.
2. Madureira AM, Ferreira MJ, Gyémánt N., et al. Rearranged jatrophane-type diterpenes from Euphorbia species: evaluation of their effects on the reversal of multidrug resistance. Planta Med. 2004 ; 70: 45-49.
3. Van Brussel JP, Oomen MA, Vossebeld PJ, et al. Identification of multidrug resistance-associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine. BJU Int. 2004 ; 93: 1333-1338.
4. Wang JH, Xia YS Effect of Shenghe Powder on expression of Bcl-2 in gastric cancer. Practical J Med Pharm. 2005 ; 22: 621-622.
5. Xia YS, Wang JH, Wu YZ Inducing differentiation effect of Shenghe Powder on C6 brain glioma cells. Lishizhen Med Materia Medica Res. 2007 ; 18: 290-291.
6. Xia YS, Wang JH, Wu YZ, Liu X. Influence of Shenghe Powder with chemotherapy on recurrence and metastatic rate of operative gastric cancer. Chin J Surg Integr Tradit West Med. 1996 ; 2: 402-405.
7. Xia YS, Wang JH, Wu YZ, Song XR, Liu X. Clinical study on treating liver metastases from digestive tract cancer with Shenghe Powder combined with interventional therapy. Lishizhen Med Materia Medica Res. 2001 ; 10: 452-454.
8. Ozben T. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett. 2006 ; 580: 2903-2909.
9. Nobili S., Landini I., Giglioni B., Mini E. Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets. 2006 ; 7: 861-879.
10. Di Nicolantonio F., Mercer SJ, Knight LA Cancer cell adaptation to chemotherapy. BMC Cancer. 2005 ; 5: 78.
11. Zhu B., Liu GT, Zhao YM, Wu RS, Strada SJ Chemosensitizing multiple drug resistance of human carcinoma by Bicyclol involves attenuated P-glycoprotein, GST-P and Bcl-2. Cancer Biol Ther. 2006 ; 5: 536-543.
12. Gan HZ, Zhang GZ, Zhao JS, et al. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Chin Med J. 2005 ; 118: 893-902.
13. Zalipsky S., Saad M., Kiwan R., et al. Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: insights of the mechanism of action. J Drug Target. 2007 ; 15: 518-530.
14. O'Connor R. The pharmacology of cancer resistance. Anticancer Res. 2007 ; 27: 1267-1272.
15. Yague E., Arance A., Kubitza L., et al. Ability to acquire drug resistance arises early during the tumorigenesis process. Cancer Res. 2007 ; 67: 1130-1137.
16. Manuguerra M., Matullo G., Veglia F., et al. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. Carcinogenesis. 2007 ; 28: 414-422.
17. Song XR, Hou SX Research progress in the reversion of traditional Chinese medicine on multidrug resistance of tumor. China J Chin Materia Medica. 2005 ; 30: 1300-1304.